Update on peripheral ulcerative keratitis
Open Access
- 1 May 2012
- journal article
- Published by Taylor & Francis Ltd in Clinical Ophthalmology
- Vol. 6, 747-754
- https://doi.org/10.2147/OPTH.S24947
Abstract
Ulcerative inflammation of the cornea occurs in the perilimbal cornea, and is associated with autoimmune collagen vascular and arthritic diseases. Rheumatoid arthritis is the most frequent underlying disease. The tendency for peripheral location is due to the distinct morphologic and immunologic characteristics of the limbal conjunctiva, which provides access for circulating immune complexes to the peripheral cornea via the capillary network. Deposition of immune complexes in the terminal ends of limbal vessels initiates immune-mediated vasculitis, and causes inflammatory cell and protein leakage due to vessel wall damage. Development of peripheral ulcerative keratitis associated with systemic disease may represent worsening of a potentially life-threatening disease. Accompanying scleritis, particularly the necrotizing form, is usually observed in severe cases, which may result in corneal perforation and loss of vision. Although first-line treatment with systemic corticosteroids is indicated for acute phases, immunosuppressive and cytotoxic agents are required for treatment of peripheral ulcerative keratitis associated with multisystem disorders. Recently, infliximab, a chimeric antibody against proinflammatory cytokine tumor necrosis factor-alpha, was reported to be effective in cases refractory to conventional immunomodulatory therapy. The potential side effects of these therapies require close follow-up and regular laboratory surveillance.Keywords
This publication has 58 references indexed in Scilit:
- Use of Infliximab in the Treatment of Peripheral Ulcerative Keratitis in Crohn DiseaseAmerican Journal of Ophthalmology, 2011
- Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart FailureCirculation, 2003
- Tetracyclines and the Treatment of Corneal Stromal UlcerationCornea, 2000
- Immunologic and Clinical Evaluation of Postsurgical Necrotizing Sclerocorneal UlcerationCornea, 1998
- Peripheral Ulcerative Keratitis and Collagen Vascular DiseaseInternational Ophthalmology Clinics, 1998
- Diagnostic Value of Anti-neutrophil Cytoplasmic Antibodies in Scleritis Associated with Wegener's GranulomatosisOphthalmology, 1992
- Tetracyclines Inhibit Connective Tissue Breakdown: New Therapeutic Implications for an Old Family of DrugsCritical Reviews in Oral Biology & Medicine, 1991
- An Analysis of Therapeutic Decision Making Regarding Immunosuppressive Chemotherapy for Peripheral Ulcerative KeratitisCornea, 1990
- Inflammatory Diseases of the Peripheral CorneaOphthalmology, 1988
- Experimental Aspects and Models of Peripheral Corneal DiseaseInternational Ophthalmology Clinics, 1986